$959 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 82 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FB | META PLATFORMS INCcl a | $34,156,000 | -33.9% | 153,605 | 0.0% | 3.56% | -40.1% | |
| BHVN | BIOHAVEN PHARMACTL HLDG CO Lcall | $23,714,000 | -14.0% | 200,000 | 0.0% | 2.47% | -22.0% | |
| SLGL | SOL GEL TECHNOLOGIES | $6,146,000 | -0.3% | 832,800 | 0.0% | 0.64% | -9.6% | |
| ACET | ADICET BIO INC | $5,492,000 | +14.2% | 275,000 | 0.0% | 0.57% | +3.4% | |
| XAIR | BEYOND AIR INC | $5,212,000 | -29.2% | 780,228 | 0.0% | 0.54% | -35.9% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $4,232,000 | -48.2% | 414,489 | 0.0% | 0.44% | -53.0% | |
| GTYH | GTY TECHNOLOGY HOLDINGS INC | $3,746,000 | -51.8% | 1,159,600 | 0.0% | 0.39% | -56.3% | |
| MTEM | MOLECULAR TEMPLATES INC | $3,524,000 | -12.0% | 1,021,317 | 0.0% | 0.37% | -20.2% | |
| SCYX | SCYNEXIS INC | $3,116,000 | -35.9% | 797,048 | 0.0% | 0.32% | -41.9% | |
| MSAC | MEDICUS SCIENCES ACQUISITION | $2,934,000 | +0.6% | 300,000 | 0.0% | 0.31% | -8.7% | |
| GNCA | GENOCEA BIOSCIENCES INC | $2,465,000 | +7.7% | 1,972,056 | 0.0% | 0.26% | -2.3% | |
| GEG | GREAT ELM GROUP INC | $2,279,000 | -13.4% | 1,259,049 | 0.0% | 0.24% | -21.5% | |
| NUVB | NUVATION BIO INC | $2,228,000 | -38.1% | 423,500 | 0.0% | 0.23% | -44.0% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $1,968,000 | +0.8% | 200,000 | 0.0% | 0.20% | -8.5% | |
| JASPER THERAPEUTICS INC | $1,917,000 | -54.8% | 540,000 | 0.0% | 0.20% | -58.9% | ||
| VINC | VINCERX PHARMA INC | $1,540,000 | -60.7% | 385,000 | 0.0% | 0.16% | -64.3% | |
| ENVVENO MEDICAL CORPORATION | $1,396,000 | -3.3% | 219,180 | 0.0% | 0.14% | -12.7% | ||
| NEXI | NEXIMMUNE INC | $497,000 | -8.6% | 117,962 | 0.0% | 0.05% | -17.5% | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $11,000 | -69.4% | 66,665 | 0.0% | 0.00% | -75.0% | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $12,000 | -45.5% | 33,332 | 0.0% | 0.00% | -66.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.